Lattice Biologics Ltd. (LBLTF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 3, 2025

Lattice Biologics Balance Sheet

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Jun '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16
Cash & Equivalents
-0.060.020.010.020.05
Cash & Short-Term Investments
-0.060.020.010.020.05
Cash Growth
-265.18%143.01%-65.74%-64.72%6.08%
Receivables
-0.290.260.170.220.42
Inventory
-0.520.71.481.852.2
Prepaid Expenses
-0.040.060.0200.1
Total Current Assets
-0.91.041.682.092.78
Property, Plant & Equipment
-1.510.490.510.340.68
Goodwill
0.610.610.610.610.610.61
Other Intangible Assets
--0.140.280.420.55
Total Assets
0.613.022.273.073.454.62
Accounts Payable
0.513.563.192.932.522.75
Accrued Expenses
-1.652.272.291.682.29
Short-Term Debt
---0.010.110.12
Current Portion of Long-Term Debt
-2.091.891.271.82.21
Current Portion of Leases
-0.160.040.030.020.03
Current Unearned Revenue
---0.03--
Other Current Liabilities
-0.370.30.420.410.38
Total Current Liabilities
0.517.837.686.976.537.79
Long-Term Debt
-0.340.20.70.440.55
Long-Term Leases
-0.5400.010.040.05
Other Long-Term Liabilities
-0.70.70.70.72.12
Total Liabilities
0.519.428.598.397.7110.51
Common Stock
11.0111.019.629.629.66.74
Retained Earnings
-10.93-17.91-16.43-15.41-14.18-12.66
Comprehensive Income & Other
0.020.490.490.470.320.02
Shareholders' Equity
0.1-6.4-6.31-5.32-4.26-5.89
Total Liabilities & Equity
0.613.022.273.073.454.62
Total Debt
-3.142.132.032.412.96
Net Cash (Debt)
--3.08-2.12-2.02-2.39-2.91
Net Cash Per Share
--0.03-0.02-0.02-0.03-0.06
Filing Date Shares Outstanding
128.22128.2293.4693.4693.2963.14
Total Common Shares Outstanding
128.22128.2293.4693.4693.2963.14
Working Capital
-0.51-6.93-6.65-5.3-4.44-5.01
Book Value Per Share
0.00-0.05-0.07-0.06-0.05-0.09
Tangible Book Value
-0.51-7.01-7.06-6.21-5.29-7.05
Tangible Book Value Per Share
-0.00-0.05-0.08-0.07-0.06-0.11
Machinery
-0.760.610.560.540.56
Construction In Progress
-0.420.210.21--
Leasehold Improvements
-0.38---0.33
Source: S&P Global Market Intelligence. Standard template. Financial Sources.